Human Hormone Drugs Market

Human Hormone Drugs Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends

Human Hormone Drugs Market

Human Hormone Drugs Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Human Hormone Drugs market is expected to grow at a CAGR of 4.3% during the forecast period.

The global Human Hormone Drugs market is estimated to be about 228.3 million US dollars in 2020.

The global Human Hormone Drugs market is estimated to reach 270.3 million USD by 2026.

The global Human Hormone Drugs market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Human Hormone Drugs market will be able to gain an advantage as they use reports as a powerful resource.

Human Hormone Drugs markets by category

Norditropin

Genotropin

Humatrope

Saizen

Omnitrope - the Somatropin Biosimilar

Somatropin Biopartners

Human Hormone Drugs Market by Application (Percentage of Demand)

Prader-Willi Syndrome

Turner Syndrome

Short Stature Homeobox Gene

Small for Gestational Age

Chronic Renal Insufficiency

Short Bowel Syndrome

Who are the leading companies in Human Hormone Drugs

Eli Lilly and Company (US)

Ferring Holding SA (Switzerland)

Genentech, Inc. (US)

GeneScience Pharmaceuticals Co., Ltd. (China)

Merck KgaA (Germany)

Novo Nordisk A/S (Denmark)

Pfizer, Inc. (US)

Sandoz International GmbH (Germany)

Human Hormone Drugs markets by region:

In North America

In Latin America

Europe

The Asia-pacific

Middle East and Africa (MEA)

What are the main countries covered

The United States

Canada

Germany

France

UK

Italy

Russia

China

Japan

Korea

Southeast Asia

India

Australia

Brazil

Mexico

Argentina

Chile

Colombia

Egypt

Saudi Arabia

United Arab Emirates

Nigeria

South Africa

Which is the most profitable market

Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Human Hormone Drugs.

What methodology did you follow in your research

This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.

Who were the primary study respondents

We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.

What are the sources of secondary research

We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Market Size Units

1.8 Review Cycle

2 Global Market Overview

2.1 Global Human Hormone Drugs Revenue and Growth Forecast 2014-2026

2.2 Global Human Hormone Drugs Market Size and Growth Forecast 2014-2026

2.3 Global Human Hormone Drugs Revenue by Region 2014-2026

2.4 Human Hormone Drugs Market Share by Major Regions 2014-2021

2.5 Human Hormone Drugs Gross Margin in Different Region 2014-2021

2.6 Global Human Hormone Drugs Market History Price and Forecast 2014-2026

2.7 Global Human Hormone Drugs Sales Market Share by Top Companies 2014-2021

3 Global Human Hormone Drugs Market by Type

3.1 Global Human Hormone Drugs Revenue and Growth Rate Segment by Types from 2014-2021

3.2 Global Human Hormone Drugs Market Size and Growth Rate Segment by Product Types from 2014-2021

3.3 Global Human Hormone Drugs Price Segment by Types from 2014-2021

3.4 Brief Introduction of Different Types

3.4.1 Norditropin

3.4.2 Genotropin

3.4.3 Humatrope

3.4.4 Saizen

3.4.5 Omnitrope - the Somatropin Biosimilar

3.4.6 Somatropin Biopartners

4 Global Human Hormone Drugs Market by Application

4.1 Global Human Hormone Drugs Revenue and Growth Rate Segment by Applications from 2014-2021

4.2 Global Human Hormone Drugs Market Size and Growth Rate Segment by Product Applications from 2014-2021

4.3 Brief Introduction of Different Applications

4.3.1 Prader-Willi Syndrome

4.3.2 Turner Syndrome

4.3.3 Short Stature Homeobox Gene

4.3.4 Small for Gestational Age

4.3.5 Chronic Renal Insufficiency

4.3.6 Short Bowel Syndrome

5 North America Human Hormone Drugs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

5.1 North America Human Hormone Drugs Value ($) from 2014-2021

5.2 North America Human Hormone Drugs Market Size from 2014-2021

5.3 North America Human Hormone Drugs Price Change from 2014-2021

5.4 North America Human Hormone Drugs Import and Export from 2014-2021

5.5 North America Human Hormone Drugs Market Value ($) and Growth (%) by Type from 2014-2021

5.6 North America Human Hormone Drugs Market Value ($) and Growth (%) by Application from 2014-2021

5.7 North America Human Hormone Drugs Market Value ($) and Growth (%) by Countries from 2014-2021

5.7.1 The United States

5.7.2 Canada

5.8 Top North America Human Hormone Drugs Participants Value ($) and Market Share (%) in 2020

6 Europe Human Hormone Drugs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

6.1 Europe Human Hormone Drugs Value ($) from 2014-2021

6.2 Europe Human Hormone Drugs Market Size from 2014-2021

6.3 Europe Human Hormone Drugs Price Change from 2014-2021

6.4 Europe Human Hormone Drugs Import and Export from 2014-2021

6.5 Europe Human Hormone Drugs Market Value ($) and Growth (%) by Type from 2014-2021

6.6 Europe Human Hormone Drugs Market Value ($) and Growth (%) by Application from 2014-2021

6.7 Europe Human Hormone Drugs Market Value ($) and Growth (%) by Countries from 2014-2021

6.7.1 Germany

6.7.2 France

6.7.3 UK

6.7.4 Italy

6.7.5 Russia

…

6.8 Top Europe Human Hormone Drugs Participants Value ($) and Market Share (%) in 2020

7 Asia-Pacific Human Hormone Drugs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

7.1 Asia-Pacific Human Hormone Drugs Value ($) from 2014-2021

7.2 Asia-Pacific Human Hormone Drugs Market Size from 2014-2021

7.3 Asia-Pacific Human Hormone Drugs Price Change from 2014-2021

7.4 Asia-Pacific Human Hormone Drugs Import and Export from 2014-2021

7.5 Asia-Pacific Human Hormone Drugs Market Value ($) and Growth (%) by Type from 2014-2021

7.6 Asia-Pacific Human Hormone Drugs Market Value ($) and Growth (%) by Application from 2014-2021

7.7 Asia-Pacific Human Hormone Drugs Market Value ($) and Growth (%) by Countries from 2014-2021

7.7.1 China

7.7.2 Japan

7.7.3 Korea

7.7.4 Southeast Asia

7.7.5 India

7.7.6 Australia

…

7.8 Top Asia-Pacific Human Hormone Drugs Participants Value ($) and Market Share (%) in 2020

8 Latin America Human Hormone Drugs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

8.1 Latin America Human Hormone Drugs Value ($) from 2014-2021

8.2 Latin America Human Hormone Drugs Market Size from 2014-2021

8.3 Latin America Human Hormone Drugs Price Change from 2014-2021

8.4 Latin America Human Hormone Drugs Import and Export from 2014-2021

8.5 Latin America Human Hormone Drugs Market Value ($) and Growth (%) by Type from 2014-2021

8.6 Latin America Human Hormone Drugs Market Value ($) and Growth (%) by Application from 2014-2021

8.7 Latin America Human Hormone Drugs Market Value ($) and Growth (%) by Countries from 2014-2021

8.7.1 Brazil

8.7.2 Mexico

8.7.3 Argentina

8.7.4 Chile

8.7.5 Colombia

…

8.8 Top Latin America Human Hormone Drugs Participants Value ($) and Market Share (%) in 2020

9 Middle East & Africa Human Hormone Drugs Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

9.1 Middle East & Africa Human Hormone Drugs Value ($) from 2014-2021

9.2 Middle East & Africa Human Hormone Drugs Market Size from 2014-2021

9.3 Middle East & Africa Human Hormone Drugs Price Change from 2014-2021

9.4 Middle East & Africa Human Hormone Drugs Import and Export from 2014-2021

9.5 Middle East & Africa Human Hormone Drugs Market Value ($) and Growth (%) by Type from 2014-2021

9.6 Middle East & Africa Human Hormone Drugs Market Value ($) and Growth (%) by Application from 2014-2021

9.7 Middle East & Africa Human Hormone Drugs Market Value ($) and Growth (%) by Countries from 2014-2021

9.7.1 Egypt

9.7.2 Saudi Arabia

9.7.3 United Arab Emirates

9.7.4 Nigeria

9.7.5 South Africa

…

9.8 Top Middle East & Africa Human Hormone Drugs Participants Value ($) and Market Share (%) in 2020

10. Global Level Competitive Intelligence – Company Profiles

10.1 Eli Lilly and Company (US)

10.1.1 Eli Lilly and Company (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.1.2 Eli Lilly and Company (US) Sales, Value, Gross and Gross Margin from 2014-2021

10.1.3 Eli Lilly and Company (US) Value and Growth Change from 2014-2021

10.1.4 Eli Lilly and Company (US) Price Change from 2014-2021

10.1.5 Eli Lilly and Company (US) Product Offered

10.2 Ferring Holding SA (Switzerland)

10.2.1 Ferring Holding SA (Switzerland) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.2.2 Ferring Holding SA (Switzerland) Sales, Value, Gross and Gross Margin from 2014-2021

10.2.3 Ferring Holding SA (Switzerland) Value and Growth Change from 2014-2021

10.2.4 Ferring Holding SA (Switzerland) Price Change from 2014-2021

10.2.5 Ferring Holding SA (Switzerland) Product Offered

10.3 Genentech, Inc. (US)

10.3.1 Genentech, Inc. (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.3.2 Genentech, Inc. (US) Sales, Value, Gross and Gross Margin from 2014-2021

10.3.3 Genentech, Inc. (US) Value and Growth Change from 2014-2021

10.3.4 Genentech, Inc. (US) Price Change from 2014-2021

10.3.5 Genentech, Inc. (US) Product Offered

10.4 GeneScience Pharmaceuticals Co., Ltd. (China)

10.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Sales, Value, Gross and Gross Margin from 2014-2021

10.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Value and Growth Change from 2014-2021

10.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Price Change from 2014-2021

10.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Product Offered

10.5 Merck KgaA (Germany)

10.5.1 Merck KgaA (Germany) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.5.2 Merck KgaA (Germany) Sales, Value, Gross and Gross Margin from 2014-2021

10.5.3 Merck KgaA (Germany) Value and Growth Change from 2014-2021

10.5.4 Merck KgaA (Germany) Price Change from 2014-2021

10.5.5 Merck KgaA (Germany) Product Offered

10.6 Novo Nordisk A/S (Denmark)

10.6.1 Novo Nordisk A/S (Denmark) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.6.2 Novo Nordisk A/S (Denmark) Sales, Value, Gross and Gross Margin from 2014-2021

10.6.3 Novo Nordisk A/S (Denmark) Value and Growth Change from 2014-2021

10.6.4 Novo Nordisk A/S (Denmark) Price Change from 2014-2021

10.6.5 Novo Nordisk A/S (Denmark) Product Offered

10.7 Pfizer, Inc. (US)

10.7.1 Pfizer, Inc. (US) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.7.2 Pfizer, Inc. (US) Sales, Value, Gross and Gross Margin from 2014-2021

10.7.3 Pfizer, Inc. (US) Value and Growth Change from 2014-2021

10.7.4 Pfizer, Inc. (US) Price Change from 2014-2021

10.7.5 Pfizer, Inc. (US) Product Offered

10.8 Sandoz International GmbH (Germany)

10.8.1 Sandoz International GmbH (Germany) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)

10.8.2 Sandoz International GmbH (Germany) Sales, Value, Gross and Gross Margin from 2014-2021

10.8.3 Sandoz International GmbH (Germany) Value and Growth Change from 2014-2021

10.8.4 Sandoz International GmbH (Germany) Price Change from 2014-2021

10.8.5 Sandoz International GmbH (Germany) Product Offered

11. Market Dynamics

11.1 Driving Factors

11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …

11.1.2 Increasing Use of Human Hormone Drugs by Different End-User/Applications

11.2 Restraints and Challenges in the Market

11.3 Opportunities

11.4 Covid-19 Impact/Evaluation

12. Future Forecast of Global Human Hormone Drugs Market from 2020-2026

12.1 Future Forecast of Global Human Hormone Drugs Market from 2020-2026 Segment by Regions

12.2 Future Forecast of Global Human Hormone Drugs Market from 2020-2026 Segment by Type

12.3 Future Forecast of Global Human Hormone Drugs Market from 2020-2026 Segment by Application

13. Investment Analysis

13.1 Fundamental Analysis (Porter's Five Forces Analysis)

13.2 Technical Preparation Analysis

13.3 Risk Evaluating Analysis

13.4 Estimated Investment Pay-Back Period

14 Research Methodology

14.1 Research Data

14.1.1 Secondary Data

14.1.2 Primary Data

14.2 Revenue Estimation

14.2.1 Bottom-Up Approach

14.2.2 Top-Down Approach (Involves time, Space, and Persons)

14.3 Data Triangulation

14.4 Assumptions

14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research

14.6 Limitations of Our Study

14.7 Scene Based Modeling

15 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Human Hormone Drugs Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What is the market share of the Human Hormone Drugs Market?
The Global Human Hormone Drugs Market share by vendor, as well as the concentration rate using the CR4, CR8 Index, determine the strength of competitive players like Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany).
How is the competition changing gears in the Human Hormone Drugs Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany) will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Who are the significant end-users in the Human Hormone Drugs Market?
The key end-users in the Human Hormone Drugs Market are (Percentage of Demand), Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome
What is the anticipated growth rate for the Human Hormone Drugs Market?
During the projected year from 2025 to 2030, the Human Hormone Drugs Market is expected to grow at a CAGR of xx%.
What are the underlying opportunities in the Human Hormone Drugs Market?
The influx of capital into the Human Hormone Drugs Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
What does the future hold for the Human Hormone Drugs Industry?
This latest research publication on the Human Hormone Drugs Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.